Search - tctmd.com

Displaying 321 - 340 of 1179

Sort: Relevancy | Date

Presentation TCT 2019

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

Presenter: Sandeep Basavarajaiah

September 26, 2019

Presentation TCT 2019

A Personal Perspective: Why I Choose Orsiro in STEMI

Presenter: Juan Fernando Iglesias

September 26, 2019

Presentation TCT 2019

The Vancouver 3M Pathway: Data Review, Practical Implementation, and the Importance of Patient-Centric Decision-Making

Presenter: Sandra Lauck

September 26, 2019

Presentation TCT 2019

Real-World Data From EASTBOURNE to TRANSFORM Trials

Presenter: Bernardo Cortese

September 26, 2019

Presentation TCT 2019

First Experience With FDA-Approved Orsiro in the USA

Presenter: Farouc Jaffer

September 26, 2019

Presentation TCT 2019

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Presenter: Alexandre Abizaid

September 26, 2019

Presentation TCT 2019

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Presenter: Philippe Genereux

September 26, 2019

Presentation TCT 2019

Why SEB Should Be Safer: Insights From Preclinical Study

Presenter: Aloke Finn

September 26, 2019

Presentation TCT 2019

Delivering Evidence

Presenter: James Hermiller

September 26, 2019

Presentation TCT 2019

Concept of MagicTouch

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

Case Presentation: Low-Risk AS

Presenter: Amisha Patel

September 26, 2019

Presentation TCT 2019

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

Presenter: Usman Baber

September 26, 2019

Presentation TCT 2019

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

Presenter: Ken Kozuma

September 26, 2019

Presentation TCT 2019

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

Presenter: Ajay Kirtane

September 26, 2019

Presentation TCT 2019

The Future in Managing Patients at High Bleeding Risk

Presenter: Elvin Kedhi

September 26, 2019

Presentation TCT 2019

Case-Based Discussion: Rely on Simplicity for Complex PCI with Second-Generation Fiber-Optic

Presenter: Evan Shlofmitz

September 26, 2019

Presentation TCT 2019

Other Transcatheter Approaches to TR Reduction: Spacer, Leaflet Grasping, and Tricuspid Valve Replacement

Presenter: Susheel Kodali

September 26, 2019

Presentation TCT 2019

Two Case Presentations Highlighting Relevant Patients

Presenter: David Kandzari

September 26, 2019

Presentation TCT 2019

Coronary Physiology: From Diagnosis to Treatment Confirmation

Presenter: Barry Uretsky

September 26, 2019

Advertisement

Use of Sirolimus-Coated Balloon (MagicTouch) in Coronary Intervention: Data and Case Examples From a Real-World Population

A Personal Perspective: Why I Choose Orsiro in STEMI

The Vancouver 3M Pathway: Data Review, Practical Implementation, and the Importance of Patient-Centric Decision-Making

Real-World Data From EASTBOURNE to TRANSFORM Trials

First Experience With FDA-Approved Orsiro in the USA

First-in-Man: Brazil ISR Experience With Angiographic and IVUS Results

Predictions for a Changing Future in AS Management: Revised Guidelines, Expanded TAVR Indications, Shifting Referral Practices, and Earlier Treatment Decisions

Why SEB Should Be Safer: Insights From Preclinical Study

Delivering Evidence

Concept of MagicTouch

Case Presentation: Low-Risk AS

TWILIGHT Thrombogenicity Substudy: Impact of Ticagrelor Alone vs. Ticagrelor Plus Aspirin on Ex-Vivo Blood Thrombogenicity in High-Risk Patients Undergoing PCI

AUGUSTUS ACS: A 2x2 Factorial Randomized Trial of Apixaban vs. Warfarin and Aspirin vs. Placebo in Patients With Atrial Fibrillation and an Acute Coronary Syndrome

MODEL U-SES: A Single-Arm Study of 3-Month DAPT in Patients Treated With a Bioabsorbable Polymer-Based Sirolimus-Eluting Stent

EVOLVE Short DAPT: A Single-Arm Study of 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

The Future in Managing Patients at High Bleeding Risk

Case-Based Discussion: Rely on Simplicity for Complex PCI with Second-Generation Fiber-Optic

Other Transcatheter Approaches to TR Reduction: Spacer, Leaflet Grasping, and Tricuspid Valve Replacement

Two Case Presentations Highlighting Relevant Patients

Coronary Physiology: From Diagnosis to Treatment Confirmation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content